At ALL, our ambition is to help people living with serious health conditions lead fuller, more independent lives, with fewer of the limitations, difficulties, and uncertainties associated with their illnesses. We strive to operate responsibly and sustainably, recognizing our responsibilities to patients who rely on our solutions, our employees, the communities in which we operate, the healthcare systems we contribute to, our shareholders, and the environment.
By 2030, ALL aims to ensure that every patient who requires its medicines in the countries where it operates can access the treatments they need. Expanding access to healthcare while creating lasting value for patients and other stakeholders is a fundamental consideration in our decision-making and long-term strategy.
Our sustainability priorities and positions have been shaped by feedback and perspectives from a broad and diverse group of stakeholders, together with the findings of our 2023 materiality assessment.